| scholarly article | Q13442814 |
| P50 | author | Erik K Flemington | Q62569596 |
| P2093 | author name string | Lu Dai | |
| Luis Del Valle | |||
| Zhiqiang Qin | |||
| Augusto C Ochoa | |||
| Denise Whitby | |||
| Wendell Miley | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| Reconstitution of an infectious human endogenous retrovirus | Q21559512 | ||
| Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements | Q24676640 | ||
| Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K | Q24678215 | ||
| Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? | Q27010373 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress | Q28472699 | ||
| Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus | Q28829309 | ||
| Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients. | Q30357883 | ||
| Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome | Q30668836 | ||
| cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. | Q33292473 | ||
| YY1 is autoregulated through its own DNA-binding sites | Q33497621 | ||
| A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus | Q33559699 | ||
| Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. | Q33667093 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution | Q34101407 | ||
| Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. | Q34309014 | ||
| Expression of human endogenous retrovirus K in melanomas and melanoma cell lines | Q40421149 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 | ||
| Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen | Q40541072 | ||
| A novel gene from the human endogenous retrovirus K expressed in transformed cells | Q40725915 | ||
| The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex | Q40752466 | ||
| Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen | Q40773245 | ||
| Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. | Q41189777 | ||
| Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype | Q41494543 | ||
| Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. | Q42707109 | ||
| Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients | Q43882758 | ||
| Cancer risk in people infected with human immunodeficiency virus in the United States | Q45395561 | ||
| Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells | Q45413740 | ||
| Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients | Q73119354 | ||
| Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients | Q74054245 | ||
| Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines | Q83827058 | ||
| Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy | Q34332052 | ||
| Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway | Q35006465 | ||
| Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation | Q35010647 | ||
| Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 | ||
| Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus | Q35453802 | ||
| Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study | Q35623269 | ||
| Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors | Q35742389 | ||
| Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases | Q35914351 | ||
| A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway | Q35983671 | ||
| Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. | Q36167973 | ||
| Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. | Q36171859 | ||
| Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma | Q36406993 | ||
| KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction | Q36457808 | ||
| Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
| Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. | Q36506932 | ||
| KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 | ||
| Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? | Q36687211 | ||
| Tumor cells expressing a retroviral envelope escape immune rejection in vivo | Q36758070 | ||
| Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer | Q36898870 | ||
| Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. | Q36911800 | ||
| HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease | Q37186225 | ||
| Keeping active endogenous retroviral-like elements in check: the epigenetic perspective | Q37279907 | ||
| Links between CD147 function, glycosylation, and caveolin-1. | Q37496744 | ||
| Human viral oncogenesis: a cancer hallmarks analysis | Q37711147 | ||
| Human herpes virus 8 in solid organ transplantation | Q37938509 | ||
| Human endogenous retroviruses and cancer | Q38982814 | ||
| Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus | Q39173806 | ||
| The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells | Q39212690 | ||
| The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2). | Q39516767 | ||
| Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites. | Q39572030 | ||
| Expression of HERV-K Correlates With Status of MEK–ERK and p16INK4A–CDK4 Pathways in Melanoma Cells | Q39651144 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 | ||
| Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo | Q40287215 | ||
| Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery | Q40390348 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Kaposi's sarcoma | Q725345 |
| Human endogenous retrovirus K | Q24975494 | ||
| P577 | publication date | 2018-05-10 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. |
| Q91693298 | Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders |
| Q91779702 | Evolutionary Medicine of Retroviruses in the Human Genome |
| Q92501277 | Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation |
| Q102059098 | High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma |
| Q91604945 | Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation |
| Q60909604 | Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies |
| Q92821650 | Virus-induced transposable element expression up-regulation in human and mouse host cells |
Search more.